Business Context and Reporting Period
This Form 8-K was filed by CytoSorbents Corporation on December 4, 2020, reporting the entry into a material definitive agreement. The Company is a Delaware corporation listed on the Nasdaq Capital Market under the symbol CTSO.
Key Financial Metrics and Debt Structure
The filing details a Third Amendment to an existing Loan and Security Agreement with Bridge Bank, a division of Western Alliance Bank. Key terms include:
- Total Credit Facility: Up to $30 million aggregate.
- Tranche Status:
- Term A Loan ($10 million): Previously drawn and repaid in full on the Amendment Date.
- Term B Loan ($5 million): Previously drawn and repaid in full on the Amendment Date.
- Term C Loan ($15 million): Available for discretionary drawdown prior to December 4, 2021.
- Re-borrowing: Repaid Term Loans may not be re-borrowed.
- Interest Rate (Term C): Floating rate of Index Rate plus 1.25%.
- Repayment Terms: Interest-only payments until an amortization date of January 1, 2023, or July 1, 2023, if an "I/O Extension Event" occurs. Principal and interest payments commence thereafter.
- Maturity Date: Extended to December 1, 2024.
The filing text does not provide specific values for revenue, profit, cash flow, margins, or overall liquidity positions outside of the specific loan terms.
Material Changes Versus Prior Period
The primary material change is the restructuring of the Company's debt facility. The Company fully repaid $15 million in existing debt (Term A and Term B) on the Amendment Date. In exchange, the maturity date for the facility was extended to December 1, 2024, and a new $15 million tranche (Term C) was made available for future drawdowns.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, revenue outlook, or management commentary regarding operational performance. The primary contingency noted is the potential extension of the interest-only period to July 1, 2023, contingent upon the occurrence of an "I/O Extension Event" as defined in the Amendment.
Important Facts for Investor Verification
- Verify the definition of the "I/O Extension Event" in the attached Exhibit 10.1 to understand the conditions for extending the interest-only period.
- Confirm the Company's current cash position to assess the ability to service the $15 million Term C Loan if drawn.
- Review the Index Rate definition to model potential interest expense volatility.
- Check subsequent filings to determine if the Term C Loan has been drawn down since December 4, 2020.